Cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early oestrogen receptor-positive breast cancer: a systematic review

Introduction Adjuvant endocrine therapy is a key treatment in oestrogen receptor positive early breast cancer (BC). For premenopausal women, ovarian function suppression (OFS) in combination with either tamoxifen or aromatase inhibitor (AI) is utilised in high-risk cases. The resultant suppression o...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ying X. Gue, Dorothy Lau, Alena Shantsila, Gregory Y.H. Lip, Carlo Palmieri
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Termedia Publishing House 2024-07-01
Σειρά:	Archives of Medical Science
Θέματα:	tamoxifen breast cancer cardiometabolic aromatase inhibitor ovarian suppression
Διαθέσιμο Online:	https://www.archivesofmedicalscience.com/Cardiovascular-and-metabolic-effects-of-ovarian-suppression-in-combination-with-tamoxifen,190743,0,2.html
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!